Dudediligence.

Johnson & Johnson

JNJNYSE · Pharmaceutical Preparations
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeAug 4 →Insiders1 insider bought $257,688 in 1 open-market buy. 8 insiders sold $87.1M, 0 of 19 sales on a 10b5-1 plan.→HoldersBlackRock 6.8%Vanguard 5.0%State Street 4.3%→Financing →PeersClosest companies: MRK, COR, GILD→

From the filings

Figures

Revenue
$97.93Blast 12 months
Net income
$21.04Blast 12 months
Operating cash flow
$22.87Blast 12 months
Cash and equivalents
$20.42Bat the last balance sheet
Total debt
$49.04Bat the last balance sheet
Shares outstanding
3.12B shareson issue
Every year and quarter →